FEATURED

OncoHost to Present PROphet® Biomarker Model that Accurately Predicts Clinical Benefit to ICI-Based Treatment at ASCO 2023

“Our goal is to provide a decision-making tool for the first-line treatment of advanced NSCLC patients based on plasma-derived biomarkers obtained before treatment initiation,” said Itamar Sela, Ph.D., VP R&D at OncoHost and lead author of the study. “Our PROphet® model continues to display strong performance, with a high correlation between the predicted clinical benefit and the observed clinical benefit rate, outperforming the current PD-L1-based prediction model. We’re excited to present this accurate alternative to improve the lives of patients.”

How Can Order Management Automation Help You Reduce Errors and Improve Customer Satisfaction?

In today's fast-paced business environment, it's more important than ever for wholesalers to stay ahead of the curve. One way to do this is...

Healthtech Leader Eon Announces 1MM Patients Impacted by Their Incidental Findings and Screening Software

Eon provides a cloud-based patient management platform that enables hospitals and health systems to capture and longitudinally track patients at risk for future catastrophic diagnoses, creating a stage shift in the early detection of cancer and possible prevention of ruptured aneurysms.

TeselaGen and NinthBio Partner to Empower Users with Advanced DNA Variant Library Construction; Announcing Homology Path Design

NinthBio and Teselagen will showcase their new integration at the SynBioBeta Conference, May 23-25 in Oakland, California. Conference attendees can view a demonstration of the integration and meet the team at Booth #58.

New App From January.ai is an AI-Powered Health Coach, Uses Generative AI to Predict Blood Sugar Response to 32MM+ Foods

Unlike a normal CGM, January AI predicts how food will impact your blood sugar, beyond only reporting what's happened. “Think of it as a weather report. If it only told you it’s already raining, you wouldn’t find it very useful,” said Noosheen Hashemi, who co-founded January AI in 2016 with Stanford University's Director of Genomics, Dr. Michael Snyder, PhD.

Nikon introduces the ECLIPSE Ni-L Upright Microscope

ECLIPSE Ni-L upright microscope features specially balanced LED illumination with properties similar to natural light. This results in more accurate displays of the original color rendition of the specimen, making it particularly effective for the observation of pathological specimens and cells.

Fresenius Kabi Awarded Technology Breakthrough Agreement with Premier, Inc. for the Ivenix Infusion System

The Ivenix Infusion System is designed to overcome deficiencies in legacy pumps. The Ivenix patented pumping technology delivers critical medications with flow that is measured and controlled to help optimize safety.

Record-breaking Donor Heart Transplant Utilizing the Paragonix SherpaPak

The Paragonix SherpaPak Cardiac Transport System is an FDA-cleared and CE-marked Advanced Organ Preservation device specifically designed to control donor heart preservation, providing physicians with stable temperature maintenance technology.

DNA Script to Unveil Industry’s Most Versatile On-site, On-Demand DNA Printer at the World’s Largest Synthetic Biology Conference

“The new STX-200 system is the next step in our quest to make biology programmable,” said Thomas Ybert, PhD, CEO and co-founder of DNA Script.
Medical Device News Magazinespot_img